시장보고서
상품코드
1831582

생리활성 창상 피복재 시장 규모, 점유율, 성장 분석 : 제품 유형별, 용도별, 최종사용자별, 작용기서별, 유통 채널별, 지역별 - 산업별 예측(2025-2032년)

Bioactive Wound Dressing Market Size, Share, and Growth Analysis, By Product Type (Antimicrobial Dressings, Hydrogels), By Application, By End User, By Mode of Action, By Distribution Channel, By Region - Industry Forecast 2025-2032

발행일: | 리서치사: SkyQuest | 페이지 정보: 영문 178 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 생리활성 창상 피복재 시장 규모는 2023년에 42억 달러로 평가되며, 2024년 46억 6,000만 달러에서 2032년에는 106억 6,000만 달러로 성장하며, 예측 기간(2025-2032년)의 CAGR은 10.9%로 성장할 전망입니다.

당뇨병성 족부궤양, 욕창, 외과적 상처, 외상성 상처, 화상 등 다양한 상처의 발생률 증가로 인해 전 세계 생물학적 활성 상처 드레싱 시장은 크게 성장하고 있습니다. 전통적인 드레싱 재료에서 생물학적 활성 대체품으로 시장이 이동하는 것은 주로 환자 결과 개선과 치유 시간 단축에 대한 수요에 의해 주도되고 있습니다. 병원과 가정 모두에서 적절한 상처 관리의 중요성에 대한 인식이 높아지면서 보급이 가속화되고 있습니다. 인구 고령화와 만성 상처 증가로 인해 전문적인 치료가 필요해지면서 시장 확대가 더욱 가속화되고 있습니다. 빛 활성화 실크 콜라겐 하이드로겔과 같은 혁신은 치유 효율을 높이고, 습윤 환경을 촉진하고, 세포 이동을 지원하며, 염증을 억제하는 화학 물질이 없는 솔루션을 제공합니다.

목차

서론

  • 조사의 목적
  • 조사 범위
  • 정의

조사 방법

  • 정보 조달
  • 2차와 1차 데이터 방법
  • 시장 규모 예측
  • 시장의 전제조건과 제한

개요

  • 세계 시장 전망
  • 공급과 수요 동향 분석
  • 부문별 기회 분석

시장 역학과 전망

  • 시장 개요
  • 시장 규모
  • 시장 역학
    • 촉진요인과 기회
    • 억제요인과 과제
  • Porter의 산업 분석

주요 시장 인사이트

  • 주요 성공 요인
  • 경쟁의 정도
  • 주요 투자 기회
  • 시장 에코시스템
  • 시장의 매력 지수(2024년)
  • PESTEL 분석
  • 거시경제 지표
  • 밸류체인 분석
  • 가격 분석

생리활성 창상 피복재 시장 규모 : 제품 유형별 & CAGR(2025-2032)

  • 시장 개요
  • 항균성 드레싱
  • 하이드로겔
  • 알긴산염
  • 콜라겐 드레싱
  • 은기반 드레싱
  • 하이드로파이버 드레싱

생리활성 창상 피복재 시장 규모 : 용도별 & CAGR(2025-2032)

  • 시장 개요
  • 만성 창상
  • 급성 창상
  • Bus
  • 수술창
  • 당뇨병성 족궤양
  • 욕창

생리활성 창상 피복재 시장 규모 : 최종사용자별 & CAGR(2025-2032)

  • 시장 개요
  • 병원
  • 클리닉
  • 홈케어 설정
  • 외래 수술 센터
  • 요양시설

생리활성 창상 피복재 시장 규모 : 작용기서별 & CAGR(2025-2032)

  • 시장 개요
  • 항균 작용
  • 항염증 작용
  • 창상 치유 촉진
  • 습기 컨트롤

생리활성 창상 피복재 시장 규모 : 유통 채널별 & CAGR(2025-2032)

  • 시장 개요
  • 온라인 판매
  • 약국
  • 병원
  • 슈퍼마켓/하이퍼마켓
  • 전문점

생리활성 창상 피복재 시장 규모 & CAGR(2025-2032)

  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 독일
    • 스페인
    • 프랑스
    • 영국
    • 이탈리아
    • 기타 유럽 지역
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 기타 라틴아메리카 지역
  • 중동 및 아프리카
    • GCC 국가
    • 남아프리카공화국
    • 기타 중동 및 아프리카

경쟁 정보

  • 상위 5사의 비교
  • 주요 기업의 시장 포지셔닝(2024년)
  • 주요 시장 기업이 채택한 전략
  • 최근 시장 동향
  • 기업의 시장 점유율 분석(2024년)
  • 주요 기업의 기업 개요
    • 기업의 상세
    • 제품 포트폴리오 분석
    • 기업의 부문별 점유율 분석
    • 매출의 전년대비 비교(2022-2024년)

주요 기업 개요

  • Smith+Nephew(UK)
  • 3 M(USA)
  • Organogenesis Inc.(USA)
  • ConvaTec Group plc(UK)
  • Molnlycke Health Care AB(Sweden)
  • Coloplast A/S(Denmark)
  • B. Braun Melsungen AG(Germany)
  • Cardinal Health(USA)
  • Integra LifeSciences Corporation(USA)
  • Johnson & Johnson(USA)
  • Medtronic plc(Ireland)
  • MiMedx Group, Inc.(USA)
  • Medline Industries, LP(USA)
  • Kerecis(Iceland)
  • Paul Hartmann AG(Germany)
  • URGO Medical(France)
  • Baxter International Inc.(USA)
  • Hollister Incorporated(USA)
  • Advanced Medical Solutions Group plc(UK)
  • Covalon Technologies Ltd.(Canada)

결론과 제안

KSA 25.10.16

Global Bioactive Wound Dressing Market size was valued at USD 4.2 billion in 2023 and is poised to grow from USD 4.66 billion in 2024 to USD 10.66 billion by 2032, growing at a CAGR of 10.9% during the forecast period (2025-2032).

The global bioactive wound dressing market is witnessing substantial growth, fueled by the increasing incidence of various wounds, including diabetic foot ulcers, pressure ulcers, surgical and traumatic wounds, as well as burns. This market transition from conventional dressings to bioactive alternatives is primarily driven by the demand for enhanced patient outcomes and quicker healing times. Greater awareness of the importance of appropriate wound care in both hospital and home settings accelerates adoption. The aging population and rising prevalence of chronic wounds necessitate specialized treatments, further supporting market expansion. Innovations like photo-activated silk-collagen hydrogels enhance healing efficiency, offering a chemical-free solution that promotes a moist environment, supports cell migration, and reduces inflammation, aligning with the trend toward bioactive materials for optimal healing and user convenience.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Bioactive Wound Dressing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Bioactive Wound Dressing Market Segments Analysis

Global Bioactive Wound Dressing Market is segmented by Product Type, Application, End User, Mode of Action, Distribution Channel and region. Based on Product Type, the market is segmented into Antimicrobial Dressings, Hydrogels, Alginates, Foams, Collagen Dressings, Silver-based Dressings and Hydrofiber Dressings. Based on Application, the market is segmented into Chronic Wounds, Acute Wounds, Bus, Surgical Wounds, Diabetic Foot Ulcers and Pressure Ulcers. Based on End User, the market is segmented into Hospitals, Clinics, Home Care Settings, Ambulatory Surgical Centers and Nursing Homes. Based on Mode of Action, the market is segmented into Antibacterial Action, Anti-inflammatory Action, Wound Healing Promotion and Moisture Control. Based on Distribution Channel, the market is segmented into Online Sales, Pharmacies, Hospitals, Supermarkets/Hypermarkets and Specialty Stores. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Bioactive Wound Dressing Market

The global bioactive wound dressing market is primarily driven by the increasing prevalence of both acute and chronic wounds, including diabetic foot ulcers, pressure injuries, surgical wounds, and traumatic injuries. These types of wounds necessitate sophisticated care solutions to promote healing and prevent infections, thereby fueling the demand for advanced wound care products. Furthermore, the growing elderly population and the rise in lifestyle-related health conditions contribute significantly to the need for specialized wound care. This convergence of factors highlights the essential role that innovative bioactive wound dressings play in meeting the evolving needs of patients and healthcare providers alike.

Restraints in the Global Bioactive Wound Dressing Market

The global bioactive wound dressing market faces significant constraints due to the high costs associated with these advanced products compared to traditional wound care options. This pricing issue particularly affects small and medium-sized hospitals, especially in developing regions, where budget constraints lead to a preference for more economical alternatives. As a result, the uptake of bioactive dressings is limited, restricting market accessibility. To enhance their market presence and boost sales volumes, companies need to focus on strategies that reduce production costs and establish competitive pricing, thereby facilitating greater adoption of bioactive wound dressings across diverse healthcare settings.

Market Trends of the Global Bioactive Wound Dressing Market

The global bioactive wound dressing market is witnessing a significant trend driven by the rising demand for advanced antimicrobial dressings. As the prevalence of chronic and surgical wounds escalates, healthcare providers are increasingly opting for dressings infused with silver, honey, or iodine to effectively combat infection during the healing process. This shift underscores a growing recognition of the critical need for innovative wound care solutions, particularly within hospital settings, where the prevention of infection is paramount for enhancing patient outcomes. As a result, the bioactive wound dressing sector is poised for robust growth, focusing on delivering cutting-edge, effective treatment options.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis

Global Bioactive Wound Dressing Market Size by Product Type & CAGR (2025-2032)

  • Market Overview
  • Antimicrobial Dressings
  • Hydrogels
  • Alginates
  • Foams
  • Collagen Dressings
  • Silver-based Dressings
  • Hydrofiber Dressings

Global Bioactive Wound Dressing Market Size by Application & CAGR (2025-2032)

  • Market Overview
  • Chronic Wounds
  • Acute Wounds
  • Bus
  • Surgical Wounds
  • Diabetic Foot Ulcers
  • Pressure Ulcers

Global Bioactive Wound Dressing Market Size by End User & CAGR (2025-2032)

  • Market Overview
  • Hospitals
  • Clinics
  • Home Care Settings
  • Ambulatory Surgical Centers
  • Nursing Homes

Global Bioactive Wound Dressing Market Size by Mode of Action & CAGR (2025-2032)

  • Market Overview
  • Antibacterial Action
  • Anti-inflammatory Action
  • Wound Healing Promotion
  • Moisture Control

Global Bioactive Wound Dressing Market Size by Distribution Channel & CAGR (2025-2032)

  • Market Overview
  • Online Sales
  • Pharmacies
  • Hospitals
  • Supermarkets/Hypermarkets
  • Specialty Stores

Global Bioactive Wound Dressing Market Size & CAGR (2025-2032)

  • North America (Product Type, Application, End User, Mode of Action, Distribution Channel)
    • US
    • Canada
  • Europe (Product Type, Application, End User, Mode of Action, Distribution Channel)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product Type, Application, End User, Mode of Action, Distribution Channel)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product Type, Application, End User, Mode of Action, Distribution Channel)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product Type, Application, End User, Mode of Action, Distribution Channel)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Smith+Nephew (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • 3M (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Organogenesis Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ConvaTec Group plc (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Molnlycke Health Care AB (Sweden)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Coloplast A/S (Denmark)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • B. Braun Melsungen AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cardinal Health (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Integra LifeSciences Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MiMedx Group, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medline Industries, LP (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Kerecis (Iceland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Paul Hartmann AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • URGO Medical (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Baxter International Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hollister Incorporated (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Advanced Medical Solutions Group plc (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Covalon Technologies Ltd. (Canada)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제